CME Group is like the NYSE or Nasdaq, but instead of company stocks, it's where professionals trade futures and options on everything from oil and gold to interest rates and stock indexes.

Major Products and Services of CME Group (CME):

• Futures and Options Trading: Operates contract markets for trading a wide range of futures and options products across various asset classes.
• Clearing House Services: Provides clearing, settling, and guaranteeing services for futures, options, and cleared swaps contracts.
• Trade Processing & Risk Mitigation: Offers services focused on processing trades and mitigating associated risks.
• Market Data Services: Supplies a range of real-time and historical market data services.

CME Group primarily sells its products and services to other companies and institutions. While specific names of customer companies are not provided in the background description, its major customers include the following categories of entities:

• Financial institutions
• Institutional investors
• Corporations (including manufacturers and producers)
• Governments
• Central banks
• Professional traders

• Equinix, Inc. (EQIX)

Terrence A. Duffy – Chairman and Chief Executive Officer

Terrence A. Duffy began his career at the Chicago Mercantile Exchange in 1980 as a broker. A year later, he founded his own firm, TDA Trading. He joined the CME board in 1995, serving as vice chairman from 1998 to 2002 and as chairman from 2002. He was appointed Chief Executive Officer in 2016. During his tenure, Duffy played a key role in the merger of CME with the Chicago Board of Trade in 2007 and the acquisition of the New York Mercantile Exchange in 2008. He also led the acquisition of NEX Group in 2018. From 2003 to 2013, he was appointed by President Bush and confirmed by the U.S. Senate to the Federal Retirement Thrift Investment Board (FRTIB).

Lynne Fitzpatrick – President and Chief Financial Officer

Lynne Fitzpatrick has served as CME Group's President and Chief Financial Officer since November 2024. She joined CME Group in 2006 and has held various positions of increasing responsibility, including Senior Managing Director and Deputy Chief Financial Officer, and Managing Director of Corporate Development and Treasurer. Before joining CME Group, Fitzpatrick worked as an investment banker at Credit Suisse and UBS. She holds a bachelor's degree in economics from Brown University and an MBA from the University of Chicago Booth School of Business. She is slated to become CEO in March 2027.

Julie Winkler – Chief Commercial Officer

Julie Winkler has served as Chief Commercial Officer of CME Group since 2016. She joined the Chicago Board of Trade (CBOT) in 1996 as a Staff Investigator in the Office of Investigations and Audits, and then as an Economist in the Business Development area in 1998. She was promoted to Managing Director, Business Development in 2004. Winkler also served as Senior Managing Director of Research, Product Development and Index Services and as Managing Director of Research and Product Development. She played a key role in the company's 2010 joint venture with Dow Jones & Company and was instrumental in developing CME Group's innovative bitcoin futures contract.

Derek Sammann – Senior Managing Director, Global Head of Commodities Markets

Derek Sammann serves as CME Group's Senior Managing Director, Global Head of Commodities Markets. He is responsible for leading the development, execution, and management of CME Group's global Commodities portfolio, including Energy, Metals, and Agricultural business lines, as well as the company's cross-asset class Options business and international growth strategy. Prior to joining CME Group in September 2006, Sammann gained over 16 years of sell-side trading experience in the global FX market. This included serving as Managing Director, Global Head of FX Options and Structured Products at Crédit Agricole Corporate & Investment Bank (formerly Calyon Corporate and Investment Bank) in London, and holding senior-level positions with Crédit Agricole Indosuez in London, Banque Indosuez in Paris, and Cooper, Neff & Associates in Chicago.

Sean P. Tully – Senior Managing Director, Global Head of Financial & OTC Products

Sean P. Tully is the Senior Managing Director, Global Head of Financial & OTC Products at CME Group, a position he was appointed to in September 2014. He joined CME Group in 2011. Previously, he served as Managing Director of Interest Rate Products and Senior Managing Director of Financial & OTC Products. Prior to CME Group, Tully led the credit and fixed income trading group at WestLB in London. He also traded interest rate derivatives at Citibank and Greenwich Capital, where he managed a global team in the interest rate swap business and worked as a proprietary trader. In 2012, he spearheaded the development and implementation of CME's Deliverable Interest Rate Swap Futures.

1. Market Confidence and Trading Volume Volatility: CME Group's revenue is directly tied to trading and clearing activity across its futures and options products. A decline in market confidence can reduce order flow and product liquidity, directly impacting the company's core business. Trading volumes are inherently variable, influenced by factors such as interest rate movements, commodity price volatility, equity market repricing, and geopolitical developments. Periods of sustained low market volatility can decrease hedging and speculative demand, making it challenging for CME Group to maintain and grow trading volumes consistently.
2. Regulatory Changes and Compliance Costs: As a major financial market infrastructure provider, CME Group operates in a highly regulated environment, facing significant regulatory scrutiny and compliance costs across various global jurisdictions. Changes in regulations can alter the economic landscape for clearing, margin requirements, and market access. Such regulatory shifts could potentially limit growth opportunities, particularly in emerging markets or new product offerings like prediction markets.
3. Competition: CME Group faces ongoing competitive pressure from rival exchanges, alternative trading venues, and over-the-counter markets. Competitors may introduce new products, offer discounted fees, or target nascent markets, potentially eroding CME Group's market share and compressing its margins. While CME Group benefits from scale and entrenched benchmark contracts, competitive dynamics remain a constant threat to its growth prospects.

The rise of decentralized finance (DeFi) platforms offering derivatives trading.

CME Group (CME) is expected to drive future revenue growth over the next 2-3 years through several strategic initiatives and market dynamics:

1. New Product Development and Innovation: CME Group is continuously launching new products and expanding its offerings across various asset classes. Recent and upcoming examples include single stock futures, 24/7 gold and crypto trading, Treasury Link, compute futures, and E-mini Equity Factor futures, which provide institutional investors with more targeted tools for managing equity exposure. These innovations aim to capture both traditional institutional business and cater to the evolving needs of a fast-changing market.
2. Growth in Market Data Services: Market data revenue has been a consistent and strong growth driver for CME Group, with a trend of consecutive quarters of year-over-year growth. This recurring revenue stream is bolstered by an increasing number of subscribers and higher fees, contributing to stable margins even during periods of fluctuating trading volumes.
3. Expansion in International and Retail Markets: The company is focused on expanding its customer base globally and within the retail segment. CME Group has reported record international average daily volumes, with significant growth in regions like Asia and EMEA. Initiatives such as the launch of event contracts and growth in micro products are key to attracting and expanding the retail investor base.
4. Increased Trading Volumes Driven by Macroeconomic Factors and Capital Efficiencies: Global macroeconomic uncertainty, geopolitical instability, and shifting supply chains are driving increased demand for risk management across all asset classes, directly translating to higher trading volumes on CME's platforms. Additionally, CME Group's efforts to provide greater capital efficiencies through expanded cross-margining and initiatives like Treasury Link attract more trading activity by reducing collateral requirements for clients.

Share Repurchases

• CME Group authorized a share repurchase program of up to $3 billion of its Class A common stock on December 5, 2024, which has no expiration date.
• In the second quarter of 2026, the company repurchased $698.2 million of common stock.
• An additional $220 million in shares were repurchased, following $695 million in Q2 2026.

Share Issuance

• In November 2021, Google made a $1 billion equity investment in CME Group, acquiring 4,584,020 shares of CME voting convertible preferred stock.

Inbound Investments

• Google's $1 billion equity investment in November 2021 for voting convertible preferred stock represents a key inbound investment.

Outbound Investments

• In September 2021, CME Group partnered with IHS Market to form OSTTRA, a provider of post-trade solutions.
• The company formed a joint venture with FanDuel in December 2025, owning 51%, to launch a prediction markets mobile app.
• OSTTRA was subsequently sold to investment funds managed by KKR & Co. for $3.1 billion in October 2025.

Capital Expenditures

• From 2021 to 2025, capital expenditures decreased while technology expenses, related to cloud migration and development from the Google Cloud partnership, increased.
• In the second quarter of 2026, capital expenditures amounted to $23.6 million.
• In Q2 2024, CME Group announced plans to build a new private Google cloud region and a co-location facility in Aurora, Illinois, to support global trading of its futures and options markets in the cloud.